Peptides and Acne: What to Know

Quick Answers

• Peptides may help acne mainly by calming inflammation, aiding barrier repair, and supporting post-blemish healing. KPV, the copper peptide GHK-Cu, and the gut-skin-axis peptide BPC-157 are the clearest examples.
• Some peptides can worsen acne, especially those that raise growth hormone (GH) and/or IGF-1 signaling: CJC-1295, Ipamorelin, GHRP-2, MK-677, IGF-1 LR3.
• Topical cosmetic peptides usually do not cause breakouts. When they do, it is typically the formula’s vehicle (heavy oils, waxes, fragrances), not the peptide itself.

Why Acne Happens (Quick Reference)

Insulin/IGF-1 → AKT → mTORC1 signaling drives sebum output, keratinocyte growth, and pro-inflammatory signals. Diets and drugs that increase IGF-1 tend to raise acne risk, while improving insulin sensitivity can reduce it.

Peptides Overview: Plausible Effects on Acne

A) Likely Neutral-to-Helpful (Anti-Inflammatory / Repair / Barrier)

KPV (Highlight)

Our top pick when inflammation and the gut-skin axis are part of the picture. KPV is a small fragment of alpha-MSH studied for inflammatory signaling, with research attention on the gut lining and the skin barrier, the two surfaces where acne-prone skin is provoked first. The research here is preclinical (gut-inflammation and antimicrobial models rather than human acne trials), but the gut-skin-axis rationale is why acne-prone customers often start with KPV-based stacks.

• Rationale: inflammatory-signaling modulation at the gut lining and skin barrier; studied for reducing intestinal inflammation and for alpha-MSH-family antimicrobial activity in laboratory settings.
• When to consider: inflamed breakouts that track with gut ups and downs; skin prone to acne, rosacea, and other types of persistent inflammation.
• Pairing: draws comfortably with GHK-Cu and BPC-157 in one syringe, the combination behind our Klow Cycle.

5-Amino-1MQ (Highlight)

Our experience suggests 5-Amino-1MQ can help acne through inflammation reduction and metabolic support. As an NNMT inhibitor, it may improve NAD+ economy and downstream inflammatory tone, with complementary benefits for body composition and energy regulation.

• Rationale: NNMT inhibition → improved metabolic and inflammatory signaling; Some customers tell us their skin settles. That is anecdote, not evidence, and we would not build a protocol on it..
• When to consider: acne linked to weight gain, insulin resistance, or systemic inflammation; as an adjunct to lifestyle changes.
• Pairing: fits well in metabolic-first stacks; combined with KPV, GHK-Cu, and BPC-157 it forms our Klow+ Cycle.

GHK-Cu (Copper Peptide)

Pro-healing, micro-circulation, and collagen support with a strong safety profile; often useful for post-acne marks and recovery.

BPC-157

Broad anti-inflammatory and pro-repair profile in preclinical and early clinical literature; supportive for tissue and the gut-skin axis.

TB-500 (Thymosin β4)

Supports actin remodeling, angiogenesis, and immune modulation, which makes it useful for tissue repair and recovery. For acne-prone customers we now reach for KPV first (see the Klow Cycle); TB-500 remains a solid option when soft-tissue repair is the bigger story.

LL-37 / Thymosin-α1 / Thymulin

Immune-modulating and antimicrobial actions. LL-37 is a host-defense peptide with activity against skin microbes, including C. acnes, in laboratory settings.

MOTS-c / Semax / Selank

May help indirectly by improving metabolic resilience (MOTS-c) or stress and sleep regulation (Semax, Selank). Not acne treatments as such, but useful neighbours.

B) Use Caution if Acne-Prone (Raise GH/IGF-1 Signaling)

CJC-1295 (with or without DAC), Ipamorelin, GHRP-2, Sermorelin, Tesamorelin, MK-677, and IGF-1 LR3 increase GH and/or IGF-1. In acromegaly, where GH and IGF-1 run very high, acne is common. That is the clearest clinical link, and it is why we would be cautious about GH-axis peptides if you break out easily.; flares often appear on oily, back, and chest areas.

• Practical: if you need these for sleep, recovery, or body-composition goals, start low, avoid stacking multiple GH-axis agents, and add standard acne care early (benzoyl peroxide + retinoid).

C) Melanocortin & Libido Peptides

MT-2 (Melanotan II) is not an acne therapy; watch for side effects unrelated to skin clarity. PT-141 is generally neutral for acne.

D) Metabolic / Weight-Centric Incretins & Amylin Analogs

Tirzepatide, retatrutide, mazdutide, and cagrilintide may improve acne indirectly by improving insulin resistance and weight. One retrospective review of insurance records noted more acne diagnoses among women taking GLP-1 receptor agonists. That is an association in billing data, not a demonstrated effect.; responses vary.

E) Reproductive-Axis / Other

Kisspeptin-10 may shift sex-hormone balance, and its effect on acne could go either way. ACE-031 and Epithalon are not known to affect acne directly.

Practical Guidance for Acne-Prone Customers

• Start with skin-friendly picks: KPV (highlight), GHK-Cu (topical or micro-dose subQ), BPC-157, and/or 5-Amino-1MQ (highlight). Our Klow and Klow+ Cycles combine these in one simple weekday protocol. Reassess in 4–6 weeks.
• Delay or minimize GH-axis stacks: if you choose CJC-1295 with or without Ipamorelin, avoid combining it with MK-677 or IGF-1 LR3 at first, and monitor for truncal acne over 2–6 weeks.
• Layer standard acne care early: benzoyl peroxide (AM) + retinoid (PM), with a non-comedogenic moisturizer and sunscreen.
• Metabolic focus: for insulin-linked patterns, consider metabolic-supportive options and track skin changes.

Recommended Cycles

The gut-to-skin beauty cycle: BPC-157 + KPV + GHK-Cu to support the gut barrier, balance the microbiome, calm inflammation, and boost collagen. Ideal for skin prone to acne, rosacea, and other types of persistent inflammation.

Everything Klow does for the gut-to-skin connection, plus 5-Amino-1MQ for cellular energy, fat metabolism, and body composition. Suited to acne linked to insulin resistance, weight, or low energy.

Key supportive peptides: KPV, GHK-Cu, BPC-157, 5-Amino-1MQ, and Semax or Selank as appropriate to the individual’s triggers and goals.

Decision Helper

• Goal is clear, calm skin, or healing and marks → Klow Cycle (BPC-157 + KPV + GHK-Cu); GHK-Cu topical as an adjunct for post-acne marks; consider 5-Amino-1MQ to keep inflammation low.
• Goal is insulin, weight, or metabolic → Klow+ Cycle; 5-Amino-1MQ adds cellular-energy, fat-metabolism, and body-composition support to the gut-to-skin cycle.
• Goal is recovery or sleep with an acne history → prefer Semax or Selank first; if needed, trial CJC-1295 alone (no MK-677) with acne prophylaxis in place.

In Summary

Acne is multifactorial. The clearest acne-friendly options emphasize anti-inflammatory and repair biology (KPV, GHK-Cu, BPC-157, 5-Amino-1MQ), combined in our Klow and Klow+ Cycles. Peptides that raise GH/IGF-1 can flare acne in susceptible users, so use them cautiously. Track your own response over 4–6 weeks and adjust.

References

The role of mTORC1 in acne pathogenesis and treatment (Melnik)
Link: https://www.researchgate.net/profile/Bodo-Melnik/publication/262795445_The_role_of_mTORC1_in_acne_pathogenesis_and_treatment/links/55eeab6f08aef559dc43cbe8/The-role-of-mTORC1-in-acne-pathogenesis-and-treatment.pdf

Acne Transcriptomics: AKT/mTORC1 signaling in acne (Cells 2023)
Link: https://www.mdpi.com/2073-4409/12/22/2600

Acromegaly presented with acne vulgaris: a retrospective study
Link: https://link.springer.com/article/10.1007/s40618-023-02254-6

CJC-1295 increases GH/IGF-1 in healthy adults (JCEM)
Link: https://academic.oup.com/jcem/article/110/1/30/7701741

LL-37 fragments as potential anti-acne agents (Pharmacol Res Perspect 2023)
Link: https://www.sciencedirect.com/science/article/pii/S0196978123000736

GHK-Cu smart dressing promotes wound healing (Chem Eng J 2024)
Link: https://www.sciencedirect.com/science/article/pii/S1385894724036416

Thymosin β4 in wound healing and tissue regeneration (Frontiers Endocrinol 2021)
Link: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.767785/full

Thymosin β4 accelerates wound healing (J Invest Dermatol)
Link: https://www.jidonline.org/article/S0022-202X%2815%2940595-0/fulltext

PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation (Dalmasso et al., 2008, Gastroenterology)
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC2431115/

Orally targeted delivery of tripeptide KPV alleviates ulcerative colitis (Xiao et al., 2017, Molecular Therapy)
Link: https://pubmed.ncbi.nlm.nih.gov/28143741/

Antimicrobial effects of alpha-MSH peptides (Cutuli et al., 2000, J Leukocyte Biology)
Link: https://pubmed.ncbi.nlm.nih.gov/10670585/

Selective and membrane-permeable NNMT inhibitors with MQ scaffold (Biochem Pharmacol 2017)
Link: https://www.sciencedirect.com/science/article/pii/S0006295217306718

Mechanism and kinetics of NNMT turnover inhibitors; notes on 5-Amino-1-methylquinolinium (J Biol Chem 2025)
Link: https://www.sciencedirect.com/science/article/pii/S0021925825003412

GLP-1 receptor agonists and acne signal in obesity care (JAAD 2025)
Link: https://www.jaad.org/article/S0190-9622%2825%2900198-7/fulltext

Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987
Link: https://pubmed.ncbi.nlm.nih.gov/29986520/

Disclaimer

This article is for educational purposes only and is not medical advice. Peptides are not approved by the FDA to diagnose, treat, cure, or prevent disease. Always consult a licensed clinician before starting any peptide, especially if you have medical conditions, take prescription medications, or are pregnant or nursing.